Company Description
Doctors and their patients get a charge out of CONMED's surgical equipment. The medical technology company develops and manufactures a wide range of...
Key CONMED Corporation Financials
| Company Type | Public - NASDAQ (GS): CNMD Main Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2007 Sales (mil.) | $694.3 |
| 2007 Employees | 3,200 |
More CONMED Corporation Financials (11 pages)
Latest CONMED Corporation Jobs jobs by Indeed
Rankings
- S&P 600
Competition
Competitive Landscape for Medical Supplies and Devices
Demand is driven by population demographics and advances in medical knowledge and technology. The profitability of individual companies depends on the ability to develop superior...
Read more about CONMED Corporation's competition across multiple industries
Top CONMED Corporation Competitors
Sponsored Links
The Business DirectoryTrading Toolbox
CONMED Corporation Executives sponsored by genius.com
| Title | Name & Bio | Contact |
|---|---|---|
| President, CEO, and Director; Interim President, Linvatec | Joseph J. (Joe) Corasanti | Network | E-mail |
| CFO and VP Finance | Robert D. Shallish Jr. | Network | E-mail |
| VP Corporate Human Resources | Beth Bowers | Network | E-mail |
More CONMED Corporation Executives
| Are You Listed On Hoover's? | ||
|---|---|---|
| Hoover's subscribers also get access to information on people who have self-listed with this company. Subscribers also have the option to add themselves to this company record. |
Tools from our advertising partners:
Current CONMED Corporation News
- CONMED Corporation (CNMD) Corporate Event Announcement Notice [Wall Street Horizon] (03 Jul 2008 20:48:00 EDT)
- CONMED Corporation (CNMD) Corporate Event Announcement Notice [Wall Street Horizon] (02 Jul 2008 20:50:00 EDT)
- Medical provider for jail to be fired: Supervisors cite broken promises, poor-quality care [Arizona Daily Star (Tucson)] (02 Jul 2008 04:00:00 EDT)
Latest Industry Video
-
Rx For Cheap Drugs (4:04)
07/23/07 5:20PM ET - Miller Tabak & Co. Pharmaceuticals Analyst Les Fundleyder and Bain & Company Partner Tim Van Biesen discuss patent expirations affecting U.S. drug costs.